Cohen & Steers
HQL

Cohen & Steers’s abrdn Life Sciences Investors HQL Stock Holding History

Cohen & Steers’s Portfolio HQL Stock Details HQL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-9,340
Closed -$126K – 402
2023
Q4 		$126K Sell
9,340
-38,000
-80% -$468K ﹤0.01% 352
2023
Q3 		$590K Sell
47,340
-30,000
-39% -$395K ﹤0.01% 267
2023
Q2 		$1.05M Sell
77,340
-5,785
-7% -$79.8K ﹤0.01% 253
2023
Q1 		$1.16M Hold
83,125
– – ﹤0.01% 245
2022
Q4 		$1.18M Hold
83,125
– – ﹤0.01% 254
2022
Q3 		$1.14M Buy
83,125
+27,636
+50% +$413K ﹤0.01% 254
2022
Q2 		$790K Sell
55,489
-10,702
-16% -$162K ﹤0.01% 268
2022
Q1 		$1.09M Sell
66,191
-59,697
-47% -$1.03M ﹤0.01% 257
2021
Q4 		$2.42M Hold
125,888
– – ﹤0.01% 200
2021
Q3 		$2.62M Hold
125,888
– – ﹤0.01% 186
2021
Q2 		$2.7M Sell
125,888
-39,707
-24% -$802K 0.01% 204
2021
Q1 		$3.26M Sell
165,595
-59,445
-26% -$1.23M 0.01% 189
2020
Q4 		$4.45M Sell
225,040
-34,926
-13% -$646K 0.01% 166
2020
Q3 		$4.57M Hold
259,966
– – 0.01% 145
2020
Q2 		$4.67M Buy
259,966
+7,434
+3% +$127K 0.01% 137
2020
Q1 		$3.78M Sell
252,532
-8,170
-3% -$134K 0.01% 161
2019
Q4 		$4.54M Buy
260,702
+58,928
+29% +$967K 0.01% 177
2019
Q3 		$3.05M Hold
201,774
– – 0.01% 230
2019
Q2 		$3.4M Buy
201,774
+8,695
+5% +$143K 0.01% 226
2019
Q1 		$3.31M Sell
193,079
-7,864
-4% -$136K 0.01% 227
2018
Q4 		$3.04M Buy
200,943
+24,875
+14% +$438K 0.01% 243
2018
Q3 		$3.6M Buy
176,068
+24,922
+16% +$496K 0.01% 249
2018
Q2 		$2.84M Buy
151,146
+4,350
+3% +$81.9K 0.01% 279
2018
Q1 		$2.82M Hold
146,796
– – 0.01% 286
2017
Q4 		$2.88M Buy
146,796
+54,428
+59% +$1.09M 0.01% 298
2017
Q3 		$1.98M Buy
92,368
+28,897
+46% +$614K 0.01% 326
2017
Q2 		$1.32M Buy
63,471
+3,918
+7% +$79.2K ﹤0.01% 354
2017
Q1 		$1.16M Buy
59,553
+18,694
+46% +$346K ﹤0.01% 368
2016
Q4 		$694K Buy
+40,859
New +$717K ﹤0.01% 360

Other funds holding HQL

SCM
Saba Capital Management New York $3.62B AUM 13% 1-Year Est. Return
AIA
Absolute Investment Advisers Rosemary Beach, Florida $852M AUM 0.1% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
1CP
1607 Capital Partners Richmond, Virginia $1.39B AUM 8.35% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return
KIM
Karpus Investment Management Pittsford, New York $3.21B AUM 6.83% 1-Year Est. Return
RL
RPO LLC Stamford, Connecticut $32.3M AUM 14.17% 1-Year Est. Return
NIM
Needham Investment Management New York $1.96B AUM 101.23% 1-Year Est. Return
FHA
Flagship Harbor Advisors Boston, Massachusetts $2.27B AUM 18.34% 1-Year Est. Return

Cohen & Steers's HQL Position: Q1 2024 in Review

Cohen & Steers sold out of abrdn Life Sciences Investors (HQL) in Q1 2024, closing a stake of 9,340 shares — an estimated $126K sold.

Cohen & Steers first reported a position in HQL in Q4 2016 and held it in 29 quarters. The position peaked at $4.67M in Q2 2020. 79 funds tracked by Wall St. Rank hold HQL as of Q1 2024.

  • Cohen & Steers reported no remaining abrdn Life Sciences Investors position as of Q1 2024 after selling out during the quarter.
  • Cohen & Steers sold 9,340 abrdn Life Sciences Investors shares in Q1 2024, an estimated $126K.
  • Cohen & Steers first reported a position in abrdn Life Sciences Investors in Q4 2016 and held it in 29 quarters.
  • Cohen & Steers's abrdn Life Sciences Investors position peaked at $4.67M in Q2 2020.
  • 79 funds tracked by Wall St. Rank held abrdn Life Sciences Investors as of Q1 2024.

Based on Cohen & Steers's 13F filing for Q1 2024, filed 15 May 2024.